Healthcare Services

Global Hyperimmune Globulins Market Forecast Highlighting Expansion And Competitive Dynamics

May 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Rise In Market Size Of The Hyperimmune Globulins Market During The Forecast Period?

The hyperimmune globulins market size has experienced strong growth in recent years. This market is set to expand from $2.06 billion in 2025 to $2.21 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.6%. Historically, this expansion can be linked to the established utilization in rabies and tetanus prophylaxis, a rising incidence of infectious diseases, the reliance on plasma-derived treatments, governmental immunization initiatives, and the development of hospital-based emergency services.

The hyperimmune globulins market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $2.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This growth trajectory during the forecast period is primarily driven by an increase in organ transplantation rates, a rise in viral infection outbreaks, the broadening of plasma donation infrastructure, continuous advancements in purification technologies, and an intensified focus on achieving rapid immune protection. Key developments expected within this period encompass an escalating demand for passive immunization therapies, greater application in post-exposure prophylaxis, increased integration into transplant and immunocompromised patient care, an expansion of plasma collection and fractionation capabilities, and the reinforcement of regulatory oversight and quality benchmarks.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16448&type=smp

Which Major Factors Are Contributing To The Development Of The Hyperimmune Globulins Market?

The hyperimmune globulin market is projected to expand due to the growing occurrence of infectious diseases. These diseases are conditions resulting from pathogenic agents like viruses, bacteria, fungi, and parasites entering the body. The rise in infectious disease prevalence stems from factors such as antimicrobial resistance, shifts in climate, and population expansion. Hyperimmune globulins offer immediate passive immunity for infectious diseases by delivering concentrated antibodies targeting specific pathogens, thereby assisting in preventing or treating conditions like rabies, hepatitis B, or tetanus. For example, a report from the UK Health Security Agency in August 2024 indicated that in 2023, the West Midlands region recorded the most measles cases, totaling 160 cases (44%), with London following at 122 cases (33%). Significantly, children under the age of 10 constituted 63% of all cases, amounting to 232 cases. Measles activity showed a considerable increase late in the year, with 157 new cases documented in December, a substantial rise from 45 cases in November. Consequently, the increasing prevalence of infectious diseases is a key driver for the growth of the hyperimmune globulin market. Hyperimmune Globulins Market Driver: Government-Led Healthcare Research And Development Initiatives A Boost For Hyperimmune Globulins

What Segment Categories Are Evaluated In The Hyperimmune Globulins Market Study?

The hyperimmune globulins market covered in this report is segmented –

1) By Type: Hepatitis B Hyperimmune Globulin, Rabies Hyperimmune Globulin, Tetanus Hyperimmune Globulin, Cytomegalovirus (CMV) Hyperimmune Globulin, Varicella-Zoster Virus (VZV) Hyperimmune Globulin, Respiratory Syncytial Virus (RSV) Hyperimmune Globulin, Other Types

2) By Route Of Administration: Intramuscular, Intravenous

3) By Application: Government Institution, Private Sector, Other Applications

Subsegments:

1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin, Intravenous Hepatitis B Hyperimmune Globulin

2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human), Rabies Immune Globulin (Equine)

3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human), Tetanus Immune Globulin (Equine)

4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation, Cmv Immune Globulin For Neonatal Infection

5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis, Vzv Immune Globulin For Immunocompromised Patients

6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children, Rsv Immune Globulin For Adults With Respiratory Conditions

7) By Other Types: Diphtheria Hyperimmune Globulin, Botulism Hyperimmune Globulin, Other Specialized Hyperimmune Globulins

Who Are The Major Companies Operating In The Hyperimmune Globulins Market?

Major companies operating in the hyperimmune globulins market are Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.

Access The Complete Hyperimmune Globulins Market Report:

https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

Which Geographic Region Represents The Largest Hyperimmune Globulins Market Share?

North America was the largest region in the hyperimmune globulins market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Hyperimmune Globulins Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16448&type=smp

Browse Through More Reports Similar to the Global Hyperimmune Globulins Market 2026, By The Business Research Company

Immunoglobulins Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Mammalian Polyclonal Immunoglobulin G Igg Antibody Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/mammalian-polyclonal-immunoglobulin-g-igg-antibody-global-market-report

Subcutaneous Immunoglobulin Scig Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795